Semarion
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Jj Thomson Ave, Cambridge, Cambridgeshir...Website
www.semarion.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Semarion
Semarion is a biotechnology startup based in Cambridge that develops advanced materials and microfabrication technologies for cell-based research. From a third-party perspective, the company is viewed as an innovative player working at the intersection of engineering and biology, aiming to simplify and improve drug discovery processes. Its core platform enables more efficient, scalable, and standardized testing of cell models, helping researchers generate higher-quality data and accelerate scientific outcomes.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Semarion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Semarion launches new products
Congratulate Masked Content for being promoted to Masked Content at Semarion
Earning: See what the market has to say on Semarion recently announced quarterly report
Check out if Semarion is spiking on competitors!
Funding: Get notified immidiatlly once Semarion has new funding data
Semarion, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Semarion has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Semarion had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Semarion
Find 3 more new buyers
Compare Similar Companies to Semarion
Compare insights from companies similar to Semarion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Semarion
<$5M
1-10
Private
$6.7M
2018
N/A
Company Profile Activity
Activity Insights
Semarion is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Semarion is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Semarion.
Semarion financials insights
Gather financial insights about Semarion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$2.9M
2026
Other Financing Round
$3.8M
Semarion Tech Stack
A closer look at the technologies used by Semarion
See more technologies
Semarion News & Media
Semarion Introduces SemaCyte Multiplexing Platform to Enhance Cell Assay Data Quality and Speed During Drug Discovery
CAMBRIDGE, England--(BUSINESS WIRE)--Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today introduced its SemaCyte® Multiplexing Platform, an expansion to the existing SemaCyte Microcarrier platform to utilize optical barcoding to accelerate screening processes during in vitro drug discovery. Designed specifically to augment microplate-based high-content imaging (HCI) apSemarion Announces Early Adopter Programme for SemaCyte Microcarrier Platform
CAMBRIDGE, England--(BUSINESS WIRE)--Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced the opening of its Early Adopter Programme for its SemaCyte® Microcarrier Platform. The platform overcomes current limitations associated with adherent cell culture and assaying workflows by enabling small colonies of cells to be moved and frozen in their adherent state,Semarion Raises £2.14 Million GBP ($2.89 Million USD) Seed Funding
CAMBRIDGE, England--(BUSINESS WIRE)--Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, announced today that it has closed a £2.14 million GBP seed funding round. The investment round was led by Parkwalk Advisors, with the University of Cambridge Seed Funds, Martlet Capital, and angel investors also contributing to the fundraise. The funding will support the commercial deve
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Semarion
Sign Up For FreeTo access detailed company insights
Semarion is a biotechnology startup based in Cambridge that develops advanced materials and microfabrication technologies for cell-based research. From a third-party perspective, the company is viewed as an innovative player working at the intersection of engineering and biology, aiming to simplify and improve drug discovery processes. Its core pla... Read More
